Evicita · Supplement evidence, graded and cited · Supplements · Lifestyle · Mechanisms · Lab tests · 中文

Acylcarnitine shuttle into mitochondria and β-oxidation

Fatty Acid Mitochondrial Translocation · Cellular bioenergetics and mitochondrial dynamics

Serves as a key co-substrate for the rate-limiting enzymes CPT-1 / CPT-2, shuttling long-chain fatty acyl groups from the cytoplasm into the mitochondrial matrix, where they are broken down to acetyl-CoA.

Why it matters: Improves myocardial metabolism during ischemia and raises endurance and the efficiency with which skeletal muscle burns fat. It also prevents ectopic lipid buildup outside the mitochondria, a buildup that triggers insulin resistance.

Molecular targets: CPT-1 (carnitine palmitoyltransferase-1), CACT transporter, β-oxidation enzyme system

Supplements acting on this mechanism (ranked by strength and evidence)

Acetyl-L-carnitine (ALCAR)

★★★☆☆Mechanism evidence: grade C

After ALCAR is taken, it can be converted to free carnitine, which serves as the shuttle substrate that carries long-chain acyl groups into mitochondria. In rats, high-dose ALCAR improved CPT1 activity in the heart of aged animals. However, whether the carnitine pool and fatty acid oxidation in human muscle change after standard oral doses is still uncertain.

Conjugated linoleic acid (CLA / Tonalin c9,t11 & t10,c12)

★★★☆☆Mechanism evidence: grade C

CLA is not a carnitine-like compound and does not take part directly in the acylcarnitine shuttle. In mice, carnitine palmitoyltransferase activity in muscle or fat tissue rose under some conditions. In a human crossover trial, 3.8 g/day of mixed CLA did not improve measured fat oxidation. The human evidence is inconsistent.

Open in the interactive app ›